Allogenetics GmbH is a startup based in Germany, most recent round Seed, 1 tracked investor.
Based in Germany, Allogenetics GmbH is a startup founded in 2023. Its most recent tracked round is Seed. Brouky records 1 investor associated with the company.
Allogenetics develops a transplantation technology that addresses organ rejection by modifying the donor organ to become immunologically invisible, eliminating the need for lifelong immunosuppression and improving graft survival and patient quality of life.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.